II. Key Market Growth Drivers

2.1 Population Aging and Evolving Disease Spectrum

Global population aging continues to accelerate, driving a steady rise in the elderly population ratio. In Japan, people aged 65 and above accounted for 29% of the total population in 2024, with the proportion expected to reach nearly 33% by 2030. Elderly groups face declining physical functions and higher incidence of chronic digestive and respiratory diseases.

According to WHO data, around 1 million new gastric cancer cases are reported globally each year, predominantly among elderly patients. The prevalence of COPD in people over 65 stands at 15%–20%. Changing lifestyles and environmental pollution have also pushed up the incidence of major cancers, including colorectal cancer with over 2 million new cases annually.

These shifts in disease patterns greatly boost demand for endoscopic minimally invasive procedures. Featuring minimal trauma and fast recovery, such techniques are highly suitable for elderly and chronic disease patients, directly fueling market expansion of endoscopic devices.

2.2 Technological Innovation and Product Upgrading

Advancing medical technology continuously drives innovation in endoscopic minimally invasive devices. In imaging technology, ultra-high-definition endoscopes, NBI endoscopes and confocal laser microendoscopes have significantly improved early lesion detection. Ultra-high-definition endoscopes deliver several times higher resolution than traditional devices, raising early cancer diagnostic accuracy by 20%–30%, while NBI technology enhances visualization of mucosal microvessels and gland structures for early disease screening.

Device development is trending toward intelligence and multi-function integration. Smart biopsy forceps equipped with sensors can identify normal and lesion tissues through impedance and spectral analysis, enabling precise sampling and reducing unnecessary biopsies. Integrated endoscopic surgical tools combine cutting, coagulation and suturing functions, effectively improving surgical efficiency. Continuous technological upgrades optimize clinical outcomes and expand application scenarios, further stimulating market growth.

2.3 Medical Insurance Support and Rising Healthcare Investment

Worldwide medical insurance policies are being optimized to expand coverage and reimbursement for endoscopic minimally invasive procedures. Since 2020, multiple regions in China have included gastroscopic and colonoscopic polypectomy, ERCP and other procedures in medical insurance schemes, with reimbursement rates of 60%–80%. This reduces patients’ medical burdens and greatly increases treatment willingness, driving device demand.

Governments globally are increasing healthcare infrastructure investment. India plans to invest USD 100 billion in medical facility upgrades from 2024 to 2031, covering endoscopic equipment procurement. The U.S. annual medical device procurement expenditure exceeds USD 50 billion. Meanwhile, medical institutions are actively upgrading endoscopic departments and accelerating equipment replacement, further supporting market expansion.

III. Regional Market Landscape

3.1 North America: Mature Market Leading High-End Demand

Benefiting from advanced medical technology, comprehensive medical insurance systems and strong consumption capacity, North America is the world’s largest endoscopic minimally invasive devices market. It achieved sales of USD 1.8 billion in 2024, accounting for 40% of the global share.

The United States leads in R&D and innovation, home to industry giants including Medtronic and Johnson & Johnson. Local hospitals show strong demand for high-end and intelligent endoscopic devices, with high market penetration of ultra-high-definition and smart surgical systems. Sound medical insurance policies further boost market demand. The North American market is expected to grow at a CAGR of 6.8% from 2025 to 2031, continuing to dominate the global high-end market.

3.2 Europe: Stable Demand Focused on Quality and Innovation

Europe features advanced medical systems and robust market demand, posting 2024 sales of USD 1.3 billion and a 29% global market share. Countries such as Germany, the UK and France impose strict standards for medical device quality, safety and innovation.

European medical institutions prioritize high-precision, reliable and innovative endoscopic products. Strict regional regulatory standards continuously drive product iteration and quality improvement. The European market is projected to maintain steady growth at a CAGR of 6.3% during 2025–2031.

3.3 Asia-Pacific: Fast-Growing Market with Huge Potential

Driven by large population bases, rapid economic growth and improving medical systems, the Asia-Pacific region is the fastest-growing market globally. Its 2024 market size reached USD 1 billion, occupying 22% of global share.

As the regional core market, China sees rising public health awareness and strengthened grassroots medical capacity. Grassroots endoscopic device procurement increased 30% year-on-year in 2024. Emerging economies including India and Indonesia also show strong growth potential thanks to increasing healthcare investment and heavy disease burdens. The Asia-Pacific market is expected to grow at a CAGR of 8.5% from 2025 to 2031, becoming the core driver of global market growth.

3.4 Other Regions: Emerging Markets with Steady Growth

Latin America, the Middle East and Africa are emerging markets for endoscopic devices. Driven by economic development, infrastructure improvement and international medical aid, regional sales reached USD 424 million in 2024, accounting for 9% of the global market.

Latin American countries are upgrading medical services and gradually increasing device demand. Middle Eastern nations invest heavily in high-end medical equipment, while African medical conditions continue to improve with international support. These regions are expected to grow at a CAGR of 7.8% during 2025–2031, with steadily rising global market influence.

Thank you for following the official platform of Vanworld! We are committed to providing you with professional, reliable and cutting-edge medical and health information.

Kind Reminder: All content released on this platform is for popular science of health knowledge only, intended to share more health-related information, and shall not replace professional medical diagnosis. Please be sure to consult a qualified doctor and strictly follow medical advice for specific diagnosis and treatment plans.

Disclaimer: The content of this article is sourced from the internet for the purpose of sharing additional information and industry insights. All viewpoints expressed herein solely belong to the original author and do not represent the stance of this platform.Should any copyright or content disputes arise, please contact us immediately. We will verify the relevant information and revise or remove the content promptly. Thank you for your understanding and support!